[18F-FDG PET/CT in patients, treated for ovarian cancer, with elevated CA 125 levels but no evidence of recurrence on conventional imaging]

Akush Ginekol (Sofiia). 2012;51(1):18-27.
[Article in Bulgarian]
No abstract available

MeSH terms

  • Adult
  • CA-125 Antigen / analysis*
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Middle Aged
  • Multimodal Imaging*
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms / diagnostic imaging*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / prevention & control*
  • Ovarian Neoplasms / surgery
  • Ovary / diagnostic imaging*
  • Ovary / pathology
  • Ovary / surgery
  • Positron-Emission Tomography*
  • Tomography, X-Ray Computed*

Substances

  • CA-125 Antigen
  • Fluorodeoxyglucose F18